Strong balance sheet, ongoing investment and new projects provide basis for increased revenues
Louvain-la-Neuve, (Belgium), 8. September 2016 – Telemis, the medical imaging, archiving and transmission specialist, has announced results for its 2015 – 2016 financial year that show a fourteenth consecutive year of profitability and a significant strengthening of the balance sheet. At the same time, the company confirms it is anticipating further growth of its PACs business in the 2016 – 2017 financial year.
In a year that saw the company pay down 38% of its debt, the latest results record a pre-tax profit of €323,631 on revenues of €6,838,864. The company’s balance sheet remains strong with equity in excess of €6.5 million.
During the financial year Telemis announced a new version of its PACS (Picture Archiving and Communication System) software that provides a number of new tools for radiologists. PACS 4.7 offers a 4-dimensional magnetic resonance examination viewer, integrated "tumor follow-up" capabilities, and a more efficient volume measurement tracking system. The work of clinicians has been further simplified through the availability of 3D visualization and the ability to transfer 360° medical imaging.
Significant among the company’s implementation successes are its ability to address the particularly demanding performance, functionality and service requirements of university teaching hospitals such as CHU (Centre Hospitalier Universitaire) Limoges. The Telemis-Medical PACS system at this 2010-bed facility has received very high levels of positive user feedback in terms of both the PACS technology and the support provided by Telemis.
The latest results were announced at the Telemis Group’s annual shareholder meeting, where Stephane Ketelaer, Telemis Group CEO, characterized the year as one of consolidation, stating: “We managed to achieve our fourteenth consecutive year of profitability despite noticeably tougher trading conditions that included budget restrictions in a number of our key markets. We took the opportunity to strengthen our balance sheet by paying down debt, we continued to invest significantly in R&D, and we secured a number of new projects.”
He added: “With revenue from many new projects being recorded in the coming financial year, plus our strengthening presence in the ‘CHU’ arena – combined with the additional benefits that the latest Telemis-Medical PACS solution can offer medical facilities around the world - we look forward to using our solid financial position to support our ongoing global business growth in 2016 – 2017 and beyond.”